Thrombocytopenic purpura patients can get better through drug treatment, but there is no cure.
1. Thrombocytopenic purpura has been renamed as immune thrombocytopenias, which belongs to acquired autoimmune diseases, and there is no cure at present, but it can be alleviated by medication and platelet counts can be restored to normal levels.
2. First-line treatment mostly adopts glucocorticoid (prednisone) and intravenous human immunoglobulin, with an effective rate of about 70%. If it is ineffective, second-line or third-line treatment can be adopted, such as TPO receptor agonist (Eltrombopag), immunosuppressant (azathioprine), splenectomy, and so on.
Immune thrombocytopenia in children is generally self-limiting and has a better prognosis than in adults. It commonly begins within days or weeks of infection or vaccination, and platelet counts return to normal within 12 months of diagnosis in 80% of cases.
Specific disease diagnosis and treatment should be directed by a physician.